225 related articles for article (PubMed ID: 2031609)
21. Urinary calcium and oxalate excretion in children.
Reusz GS; Dobos M; Byrd D; Sallay P; Miltényi M; Tulassay T
Pediatr Nephrol; 1995 Feb; 9(1):39-44. PubMed ID: 7742220
[TBL] [Abstract][Full Text] [Related]
22. [Type I oxalosis in childhood--studies within the scope of terminal renal failure in the child].
Frosch M; Kuwertz-Bröking E; Bulla M; von Bassewitz DB; Leusmann DB
Klin Wochenschr; 1989 Nov; 67(22):1156-67. PubMed ID: 2586021
[TBL] [Abstract][Full Text] [Related]
23. Plasma oxalate concentration and oxalate distribution volume in patients with normal and decreased renal function.
Prenen JA; Dorhout Mees EJ; Boer P
Eur J Clin Invest; 1985 Feb; 15(1):45-9. PubMed ID: 3921382
[TBL] [Abstract][Full Text] [Related]
24. Clearance and removal of oxalate in children on intensified dialysis for primary hyperoxaluria type 1.
Illies F; Bonzel KE; Wingen AM; Latta K; Hoyer PF
Kidney Int; 2006 Nov; 70(9):1642-8. PubMed ID: 16955107
[TBL] [Abstract][Full Text] [Related]
25. [Normal values of calcium and oxalate excretion in children].
Reusz G; Szabó A; Byrd DJ; Dobos M; Sallay P; Tulassay T
Orv Hetil; 1996 Apr; 137(16):861-3. PubMed ID: 8657414
[TBL] [Abstract][Full Text] [Related]
26. Prolonged survival after renal transplantation in primary hyperoxaluria of childhood.
Leumann EP; Wegmann W; Largiadèr F
Clin Nephrol; 1978 Jan; 9(1):29-34. PubMed ID: 343953
[TBL] [Abstract][Full Text] [Related]
27. Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1.
Hoppe B; Beck B; Gatter N; von Unruh G; Tischer A; Hesse A; Laube N; Kaul P; Sidhu H
Kidney Int; 2006 Oct; 70(7):1305-11. PubMed ID: 16850020
[TBL] [Abstract][Full Text] [Related]
28. Plasma oxalate following kidney transplantation in patients without primary hyperoxaluria.
Elgstoen KB; Johnsen LF; Woldseth B; Morkrid L; Hartmann A
Nephrol Dial Transplant; 2010 Jul; 25(7):2341-5. PubMed ID: 20167571
[TBL] [Abstract][Full Text] [Related]
29. Plasma level and renal clearance of oxalate in normal subjects and in patients with primary hyperoxaluria or chronic renal failure or both.
Constable AR; Joekes AM; Kasidas GP; O'Regan P; Rose GA
Clin Sci (Lond); 1979 Apr; 56(4):299-304. PubMed ID: 477214
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic expression of primary hyperoxaluria: comparative features of types I and II.
Milliner DS; Wilson DM; Smith LH
Kidney Int; 2001 Jan; 59(1):31-6. PubMed ID: 11135054
[TBL] [Abstract][Full Text] [Related]
31. The effect of pyridoxine on oxalate dynamics in three cases of primary hyperoxaluria (with glycollic aciduria).
Watts RW; Veall N; Purkiss P; Mansell MA; Haywood EF
Clin Sci (Lond); 1985 Jul; 69(1):87-90. PubMed ID: 4064559
[TBL] [Abstract][Full Text] [Related]
32. Plasma oxalate in relation to eGFR in patients with primary hyperoxaluria, enteric hyperoxaluria and urinary stone disease.
Perinpam M; Enders FT; Mara KC; Vaughan LE; Mehta RA; Voskoboev N; Milliner DS; Lieske JC
Clin Biochem; 2017 Dec; 50(18):1014-1019. PubMed ID: 28764885
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of a high-performance liquid chromatography method for urinary oxalate determination and investigation regarding the pediatric reference interval of spot urinary oxalate to creatinine ratio for screening of primary hyperoxaluria.
Shen Y; Luo X; Li H; Guan Q; Cheng L
J Clin Lab Anal; 2021 Aug; 35(8):e23870. PubMed ID: 34097312
[TBL] [Abstract][Full Text] [Related]
34. Urinary oxalate, glycolate, glyoxylate, and citrate after acute intravenous administration of glyoxylate in rats.
Ogawa Y; Miyazato T; Morozumi M; Sugaya K; Hatano T
Mol Urol; 2000; 4(4):341-8. PubMed ID: 11156701
[TBL] [Abstract][Full Text] [Related]
35. Measurement of plasma oxalate in healthy subjects and in patients with chronic renal failure using immobilised oxalate oxidase.
Kasidas GP; Rose GA
Clin Chim Acta; 1986 Jan; 154(1):49-58. PubMed ID: 3943224
[TBL] [Abstract][Full Text] [Related]
36. Endogenous Oxalate Production in Primary Hyperoxaluria Type 1 Patients.
Garrelfs SF; van Harskamp D; Peters-Sengers H; van den Akker CHP; Wanders RJA; Wijburg FA; van Goudoever JB; Groothoff JW; Schierbeek H; Oosterveld MJS
J Am Soc Nephrol; 2021 Dec; 32(12):3175-3186. PubMed ID: 34686543
[TBL] [Abstract][Full Text] [Related]
37. Hydroxyproline-induced hyperoxaluria using acidified and traditional diets in the porcine model.
Kaplon DM; Penniston KL; Darriet C; Crenshaw TD; Nakada SY
J Endourol; 2010 Mar; 24(3):355-9. PubMed ID: 20078233
[TBL] [Abstract][Full Text] [Related]
38. Effect of vitamin D3 on the conversion of ethylene glycol to glycolate and oxalate in ethylene glycol-fed rats.
Halabe A; Shor R; Wong NL; Sutton RA
Clin Chim Acta; 2003 Apr; 330(1-2):135-9. PubMed ID: 12636932
[TBL] [Abstract][Full Text] [Related]
39. Hydroxyproline Metabolism and Oxalate Synthesis in Primary Hyperoxaluria.
Fargue S; Milliner DS; Knight J; Olson JB; Lowther WT; Holmes RP
J Am Soc Nephrol; 2018 Jun; 29(6):1615-1623. PubMed ID: 29588429
[No Abstract] [Full Text] [Related]
40. Nephrocalcinosis in a patient with primary hyperoxaluria type 2.
Kemper MJ; Müller-Wiefel DE
Pediatr Nephrol; 1996 Aug; 10(4):442-4. PubMed ID: 8865239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
